Abstract
In the textbook “Respiratory Diseases”, published in 1981, Crofton and Douglas 1 commenced the discussion of asthma management with the comment “It must be admitted that the treatment of asthma is largely palliative”. The chapter provides a bleak picture of high mortality, frequent symptoms,and disabling side-effects of treatment. The use of inhaled corticosteroids (ICS) and, later, long-acting β2-agonists, has produced extraordinary improvements in asthma outcomes, particularly in the burden of disease for patients. More recent attention has focussed on fine-tuning asthma treatment, the aim being to return the patient towards the disease-free state, i.e. not just to improve lung function, which has long been the preferred outcome variable for clinical trials, but to improve the whole spectrum of asthma features, summarised in the expression “asthma control”.

This publication has 18 references indexed in Scilit: